Kinsale Capital Group, Inc. (KNSL) Stock Price & Analysis
Kinsale Capital Group, Inc. (KNSL) rose 1.40% to USD 303.25 as of June 10, 2026 at 00:54 UTC, according to Nexqual real-time market data.
KNSL last closed at USD 299.07; the session ranged USD 299.17–305.98 on volume of 161,485 shares. Market capitalization is $6.99B, with a 52-week range of USD 287.2–512.76 (NYQ). Source: Nexqual, June 10, 2026 at 00:54 UTC.
Key Statistics (as of June 10, 2026 at 00:54 UTC)
| Price | USD 303.25 |
|---|---|
| Change | ▲ 1.40% (up) |
| Previous Close | USD 299.07 |
| Open | USD 301.34 |
| Day Range | USD 299.17 – 305.98 |
| 52-Week Range | USD 287.2 – 512.76 |
| Volume | 161,485 shares |
| Market Cap | $6.99B |
| Exchange | NYQ |
Technical Analysis (KNSL)
Nexqual's technical model rates KNSL "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:54 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.75 (neutral) |
| vs SMA50 | Below (USD 324.73) |
| MACD | -6.58 (negative) |
Analyst Ratings (KNSL)
Wall Street analysts rate KNSL "Hold" based on 9 analysts, with a mean price target of USD 354.67 (range USD 267–442), per Nexqual as of June 10, 2026 at 00:54 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 354.67 |
| High Target | USD 442 |
| Low Target | USD 267 |
| Buy / Hold / Sell | 1 / 9 / 2 |
Earnings (KNSL)
| Next Earnings Date | 2026-07-23 |
|---|---|
| EPS Estimate | USD 5.08 |
| Revenue Estimate | $477.79M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 5.11 vs est 4.68 ▲ beat |
| 2025-12-31 | USD 5.81 vs est 5.31 ▲ beat |
| 2025-09-30 | USD 5.21 vs est 4.82 ▲ beat |
| 2025-06-30 | USD 4.78 vs est 4.42 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Financials & Fundamentals (KNSL)
| Total Revenue | $1.92B |
|---|---|
| Revenue Growth (YoY) | +10.20% |
| Gross Margin | +29.27% |
| Operating Margin | +30.60% |
| Profit Margin | +27.48% |
| ROE | +29.68% |
| Debt / Equity | 11.41 |
| Current Ratio | 0.2 |
| Total Cash | $223.26M |
| Total Debt | $224.47M |
| Free Cash Flow | $976.74M |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Financial Health Score (KNSL)
Nexqual rates Kinsale Capital Group, Inc.'s overall financial health "Strong" across five dimensions, as of June 10, 2026 at 00:54 UTC.
| Growth | Strong — Revenue +18% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 29% |
| Balance Sheet | Solid — $223M cash vs $224M debt |
| Cash Flow | Strong — FCF $977M, 52% margin |
| Efficiency | Strong — ROE 30%, ROA 7.4% |
Ownership (KNSL)
| Insider Ownership | +5.36% |
|---|---|
| Institutional Ownership | +97.41% |
| Shares Outstanding | 23.06M |
| Float | 21.80M |
| Short % of Float | +12.66% |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Leadership (KNSL)
Kinsale Capital Group, Inc. is led by Michael Patrick Kehoe (age 59), Chairman of the Board, CEO & President, per Nexqual as of June 10, 2026 at 00:54 UTC.
| Chairman of the Board, CEO & President | Michael Patrick Kehoe (age 59) |
|---|---|
| Executive VP, CFO & Treasurer | Bryan Paul Petrucelli (age 59) |
| Senior Vice President of Underwriting | Brendan McMorrow |
Major Backers & Investors (KNSL)
Notable institutional backers of Kinsale Capital Group, Inc. include BAMCO Inc., Capital Group, BARON INVESTMENT Fd.S TRT -Baron Growth Fd., according to Nexqual as of June 10, 2026 at 00:54 UTC.
Active Investors
| Investor | Stake |
|---|---|
| BAMCO Inc. | 8.79% |
| Capital Group | 5.69% |
| BARON INVESTMENT Fd.S TRT -Baron Growth Fd. | 5.35% |
| First Manhattan Co. LLC | 2.67% |
| Morgan Stanley | 2.57% |
| Life Cycle Investment Partners Ltd | 2.45% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 14.77% |
| BlackRock | 12.66% |
| State Street | 3% |
| Geode Capital | 2.87% |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
From Kinsale Capital Group, Inc.'s Latest SEC 10-K Filing (filed 2026-02-20)
Key Strengths & Strategy (as disclosed to the SEC)
- Using our proprietary technology platform and leveraging the expertise of our highly-experienced employees in our daily operations, we have built a company that is entrepreneurial and highly efficient.
- We believe that the combination of our proprietary technology platform and our expense management allows us to process quotes, underwrite policies and operate with a substantial cost advantage over our direct competitors.
- We use our proprietary technology platform to drive a high level of efficiency, accuracy and speed in our underwriting and quoting process.
- We have built a proprietary technology platform that reflects the best practices our management team has learned from its extensive experience.
Partnerships
- Our investment policy is designed to comply with the regulatory investment requirements and restrictions to which our insurance subsidiary is subject.
- Trade Representative announced their intention to exercise their authority under the Dodd-Frank Act to negotiate a "covered agreement" with the European Union (the "Covered Agreement").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WD | Walker & Dunlop, Inc | USD 52.89 | ▲ 3.2% |
| LOB | Live Oak Bancshares, Inc. | USD 38.63 | ▲ 3.26% |
| MEDP | Medpace Holdings, Inc. | USD 466.79 | ▲ 2.76% |
| FLGT | Fulgent Genetics, Inc. | USD 18.5 | ▼ 3.39% |
| APPN | Appian Corporation | USD 24.05 | ▼ 2.75% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:54 UTC. This page is informational and not investment advice.